SCHEMBL6904692

SCHEMBL6904692

CCOC(=O)CCCc1cccc(C(C)C)c1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 3/20 0.53
CYP4A11 Q02928 3/20 0.53
CYP1A2 P05177 2/20 0.48
CYP3A4 P08684 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
NLRP3 Q96P20 3/20 0.47
ALOX5 P09917 1/20 0.42
ALDH1A1 P00352 1/20 0.42
GAA P10253 1/20 0.42
FAAH O00519 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
LMNA P02545 1/20 0.42
GABRA1 P14867 1/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42
GABRB1 P18505 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6902265 0.92 CYP4F2 (0.56) CYP4F2CYP4A11CYP1A2CYP3A4SMN1; SMN2
SCHEMBL6904647 0.90 CYP4F2 (0.51) CYP4F2CYP4A11CYP1A2CYP3A4SMN1; SMN2
SCHEMBL20030391 0.87 CYP4F2 (0.61) CYP4F2CYP4A11CYP1A2CYP3A4SMN1; SMN2
SCHEMBL28072636 0.83 CYP4F2 (0.58) CYP4F2CYP4A11CYP1A2CYP3A4SMN1; SMN2
SCHEMBL4658129 0.81 CYP4F2 (0.48) CYP4F2CYP4A11CYP1A2CYP3A4SMN1; SMN2
SCHEMBL5598458 0.81 MAPK1 (0.46) CYP4F2CYP4A11CYP1A2CYP3A4NLRP3
SCHEMBL6902810 0.81 CYP4F2 (0.54) CYP4F2CYP4A11SMN1; SMN2NLRP3ALDH1A1
SCHEMBL17284798 0.81 CYP4F2 (0.56) CYP4F2CYP4A11CYP1A2CYP3A4SMN1; SMN2
SCHEMBL27501902 0.81 CYP4F2 (0.56) CYP4F2CYP4A11CYP1A2CYP3A4SMN1; SMN2
SCHEMBL6901879 0.78 SLC6A2 (0.42) CYP4F2CYP4A11CYP1A2CYP3A4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1430017-A2 SUBSTITUTED PHENOL COMPOUNDS USEFUL FOR ANESTHESIA AND SEDATION Theravance, Inc. (US) 2004-06-23 EP disclosed
WO-2003026632-A2 SUBSTITUTED PHENOL COMPOUNDS USEFUL FOR ANESTHESIA AND SEDATION THERAVANCE, INC. (US) 2003-04-03 WO disclosed